JASON CORNELIO: Open Payments
NPI 1730569740 · BLOOMFIELD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$498 in 18 payments from 8 companies in 2025. Trend: 2023 $354 · 2024 $613 · 2025 $498
Food & beverage: $498
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 7 | $181 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $163 |
| Alnylam Pharmaceuticals Inc. | 1 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $30 |
| AstraZeneca Pharmaceuticals LP | 1 | $27 |
| BridgeBio Pharma, Inc. | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| Abbott Laboratories | 1 | $17 |
Products named: VYNDAQEL, LifeVest, Kerendia, WAINUA, Attruby, VERQUVO, CARDIOMEMS.
Industry payments across CT — which companies pay providers there.
